MOEXIPRIL Drug Patent Profile

Which patents cover Moexipril, and when can generic versions of Moexipril launch?

Moexipril is a drug marketed by Apotex Inc, Chartwell Rx, Glenmark Pharms Ltd, Teva, Glenmark Pharms, and Heritage. and is included in eight NDAs.

The generic ingredient in MOEXIPRIL is hydrochlorothiazide; moexipril hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.

Summary for MOEXIPRIL

US Patents:	0
Applicants:	6
NDAs:	8
DailyMed Link:	MOEXIPRIL at DailyMed

US Patents and Regulatory Information for MOEXIPRIL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex Inc	MOEXIPRIL HYDROCHLORIDE	moexipril hydrochloride	TABLET;ORAL	078454-001	Jun 2, 2008		DISCN	No	No
Teva	MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; moexipril hydrochloride	TABLET;ORAL	076980-001	Mar 7, 2007		RX	No	No
Teva	MOEXIPRIL HYDROCHLORIDE	moexipril hydrochloride	TABLET;ORAL	076204-001	May 8, 2003	AB	RX	No	No
Chartwell Rx	MOEXIPRIL HYDROCHLORIDE	moexipril hydrochloride	TABLET;ORAL	077536-002	Nov 30, 2006	AB	RX	No	No
Glenmark Pharms	MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; moexipril hydrochloride	TABLET;ORAL	090718-001	Mar 17, 2010		DISCN	No	No
Teva	MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; moexipril hydrochloride	TABLET;ORAL	076980-002	Mar 7, 2007		RX	No	Yes
Teva	MOEXIPRIL HYDROCHLORIDE	moexipril hydrochloride	TABLET;ORAL	076204-002	May 8, 2003	AB	RX	No	Yes